About Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi
During the past decade, Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on
average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi"
#1 collaborator was "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi
According to Clinical.Site data, the most researched conditions in "Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi" are
"Follicular Lymphoma" (2 trials), "Immune Thrombocytopenia" (2 trials), "Adult Patients" (1 trials), "Chronic Lymphocyte Leukemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi" in a lesser frequency.
Clinical Trials Intervention Types at Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi
Most popular intervention types in "Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (3 trials), "Ibrutinib" (2 trials), "Bendamustine" (1 trials), "Copanlisib" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi
The vast majority of trials in "Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi" are
11 trials for "All" genders.
Clinical Trials Status at Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi
Currently, there are NaN active trials in "Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".